Current News
November 4, 2009
FDA Classifies Synthes' Voluntary Medical Device Recall of Synex II Central Body Components as a Class I Recall
October 21, 2009
Synthes Reports Local Currency Sales Growth of 10.0% for Third Quarter 2009 and Maintains Double-Digit Sales Growth through First Nine Months 2009
Company Profile for Investors
Synthes is a leading global medical device company, employing approximately 10,000 people to improve patient care around the world. Its headquarters are in West Chester, PA (USA).
Through its five business units (Trauma, Spine, Cranio-Maxillofacial, Biomaterials and Power Tools) Synthes develops, produces and markets instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues.
The company operates in product markets with high growth, driven by the ageing population and improvements in technology that allow treating more patients with better implants.
Over the last 10 years (1998–2008) Synthes has increased its revenues from US$ 435 million to US$ 3.2 billion, representing a CAGR of 22.1%, including the acquisition of Stratec Medical in 1999 and Mathys in 2004.